EMA Authorised: Arsenic trioxide medac (arsenic trioxide) — medac Gesellschaft für klinische Spezialpräparate mbH

View source ↗

Summary

EMA authorised Arsenic trioxide medac for the treatment of acute promyelocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Arsenic trioxide medac (arsenic trioxide)

Snippet

Status: Authorised. Therapeutic area: Leukemia, Promyelocytic, Acute. MAH: medac Gesellschaft für klinische Spezialpräparate mbH. Decision date: 21/04/2026